MiR-21 经 TGF-β/Smad 通路下调 Smad7 调控瘢痕疙瘩形成
本研究探讨瘢痕疙瘩形成机制,通过微阵列与实时 PCR 发现瘢痕疙瘩及其成纤维细胞中 miR-21 表达显著上调;蛋白水平证实 miR-21 过表达可促进瘢痕疙瘩纤维化,低表达可抑制该过程;miR-21 经 TGF-β/Smad 通路负调控下游靶基因 Smad7 参与纤维化。
要点
- 瘢痕疙瘩及瘢痕疙瘩成纤维细胞中 miR-21 表达显著上调。
- miR-21 过表达促进瘢痕疙瘩纤维化,低表达则抑制该过程。
- miR-21 经 TGF-β/Smad 通路负调控 Smad7 参与瘢痕疙瘩纤维化。
核心结论
- miR-21 通过 TGF-β/Smad 通路负调控下游靶基因 Smad7,参与瘢痕疙瘩纤维化过程。
研究设计与样本
- 基础实验研究:采用 microRNA 微阵列与实时聚合酶链反应检测瘢痕疙瘩及瘢痕疙瘩成纤维细胞中 miR-21 表达,并在蛋白水平验证 miR-21 对纤维化的作用。
主要发现
- microRNA 微阵列与实时 PCR 显示瘢痕疙瘩及瘢痕疙瘩成纤维细胞中 miR-21 表达显著上调。
- 蛋白水平证实 miR-21 过表达可在一定程度上促进瘢痕疙瘩纤维化过程。
- 低表达 miR-21 可抑制瘢痕疙瘩纤维化过程。
- miR-21 经 TGF-β/Smad 通路负调控下游靶基因 Smad7 参与瘢痕疙瘩纤维化。
临床怎么用
- 为瘢痕疙瘩临床治疗提供新理论支持,miR-21–Smad7–TGF-β/Smad 轴可作为后续研究与干预的候选方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A keloid is a benign fibroproliferative skin tumor that results from abnormal wound healing after injury and tends to grow beyond the boundary of the original wound; the mechanism of keloid formation is still unclear. MicroRNA-21 (MiR-21) is a representative microRNA that plays a key role in a variety of fibrotic diseases via the transforming growth factor-β/Smad signaling pathway. The aim of our study was to explore the mechanism of keloid formation. First, we found that the expression of miR-21 in keloids and keloid fibroblasts was significantly upregulated by microRNA microarray and real-time polymerase chain reaction. Additionally, at the protein level, our study confirmed that the overexpression of miR-21 could promote the process of keloid fibrosis to some extent and also indicated that a low expression of miR-21 could inhibit the process of keloid fibrosis. Finally, the results proved that miR-21 could participate in the keloid fibrosis process through negative regulation of its downstream target gene Smad7 via the transforming growth factor-β/Smad signaling pathway, which provides a guiding framework for further studies and new theoretical support for keloid clinical treatment.
引用
- Wu J, Fang L, Cen Y, et al. MiR-21 Regulates Keloid Formation by Downregulating Smad7 via the TGF-β/Smad Signaling Pathway. J Burn Care Res. 2019. PMID: 31184708. doi:10.1093/jbcr/irz089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。